Loading…
Reported covered position: LA, LD & Sr. Policy Advisor, Rep. Joe Pitts R-PA
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · 3T
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Source: Senate LDA
| BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) | 48 | 2016–2026 |
| BEST BUY CO INC | 43 | 2008–2018 |
| ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) | 41 | 2013–2023 |
| U. S. CENTER FOR SAFESPORT | 40 | 2017–2026 |
| AIRBNB | 38 | 2018–2026 |
| CVS HEALTH | 38 | 2016–2026 |
| AMERICA'S HEALTH INSURANCE PLANS (AHIP) | 37 | 2019–2026 |
| CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) | 37 | 2018–2026 |
| PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) | 37 | 2012–2026 |
| RETAIL INDUSTRY LEADERS ASSOCIATION (RILA) | 25 | 2008–2017 |
| NATIONAL PATIENT ADVOCATE FOUNDATION | 19 | 2010–2013 |
| BIPARTISAN POLICY CENTER ADVOCACY NETWORK(FOR KNWN AS BIPARTISAN ADVOCACY CENTER | 18 | 2008–2013 |
| FUELS AMERICA | 17 | 2015–2018 |
| REFLEXION MEDICAL | 17 | 2022–2026 |
| VARIAN MEDICAL SYSTEMS, INC. | 17 | 2008–2012 |
| VOLVO CAR CORPORATION | 17 | 2017–2020 |
| RESEARCH!AMERICA | 16 | 2023–2025 |
| ABBOTT LABORATORIES | 15 | 2022–2026 |
| CRICKET COMMUNICATIONS, INC. | 15 | 2008–2011 |
| AMERICAN CLINICAL LABORATORY ASSOCIATION | 14 | 2023–2026 |
| APOTEX, CORP. | 13 | 2024–2026 |
| ADVAMED IMAGING | 12 | 2024–2026 |
| NUCLEAR ENERGY INSTITUTE (NEI) | 12 | 2008–2010 |
| GLASSDOOR, INC. | 10 | 2015–2017 |
| OPTIMUM COMMUNICATIONS (FORMERLY REPORTING AS ALTICE USA, INC.) | 10 | 2022–2024 |
| T-MOBILE USA, INC. | 10 | 2020–2022 |
| UNIVISION COMMUNICATIONS INC. | 10 | 2016–2018 |
| GROWTH ENERGY | 9 | 2009–2010 |
| MILLER/WENHOLD CAP.STRATEGIES ON BEHALF OF TAXICAB,LIMOUSINE&PARATRANSIT ASSN | 9 | 2015–2017 |
| NATIONAL FENESTRATION RATING COUNCIL | 9 | 2007–2009 |
| NETFLIX INC | 9 | 2011–2013 |
| AMERICAN CHEMISTRY COUNCIL | 8 | 2011–2012 |
| HTC AMERICA, INC. | 8 | 2012–2013 |
| Hims & Hers Health, Inc. | 8 | 2025–2026 |
| TEVA PHARMACEUTICALS USA INC | 8 | 2017–2018 |
| THE INTERNET ASSOCIATION | 8 | 2013–2014 |
| THE WEIDT GROUP | 8 | 2010–2012 |
| CONSTELLATION ENERGY GENERATION, LLC, FORMERLY REPORTING AS EXELON CORPORATION | 7 | 2009–2010 |
| FMC CORPORATION | 7 | 2014–2020 |
| MCKESSON CORPORATION | 7 | 2025–2026 |
| NEMOURS | 7 | 2009–2011 |
| AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING | 6 | 2025–2026 |
| CLEAN SLATE INITIATIVE, INC. (CSI) | 6 | 2024–2025 |
| FEDERAL HOME LOAN MORTGAGE CORP | 6 | 2008 |
| UNUM GROUP | 6 | 2015–2024 |
| ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) | 5 | 2016–2025 |
| INTERNATIONAL FRANCHISE ASSOCIATION (IFA) | 5 | 2022–2026 |
| PERSONAL CARE PRODUCTS COUNCIL | 5 | 2008–2009 |
| CH2MHILL | 4 | 2007–2008 |
| CYREN CALL COMMUNICATIONS | 4 | 2007–2008 |
| GAP INC. | 4 | 2009–2010 |
| HEARTFLOW, INC. | 4 | 2026 |
| NATIONAL BREAST CANCER COALITION | 4 | 2008–2009 |
| PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) | 3 | 2026 |
| SLACK TECHNOLOGIES, INC. | 3 | 2016 |
| DIALYSIS PATIENT CITIZENS | 2 | 2021–2022 |
| GENERAL ELECTRIC COMPANY | 2 | 2014 |
| GLENMARK PHARMACEUTICALS, INC., USA | 2 | 2020 |
| HIGHMARK INC. | 2 | 2026 |
| ICI (INFRARED CAMERAS, INC.) | 2 | 2021 |
| MERCHANT CUSTOMER EXCHANGE LLC ("MCX") | 2 | 2015 |
| NATIONAL JOB CORPS ASSOCIATON | 2 | 2025 |
| OXFAM AMERICA | 2 | 2007 |
| STANTON PARK GROUP (SPG) | 2 | 2007 |
| STREAMLINED SALES TAX GOVERNING BOARD, INC. | 2 | 2014 |
| THE COCA-COLA COMPANY | 2 | 2026 |
| UNITED WAY WORLDWIDE (UWW) | 2 | 2026 |
| ADVANCED PARTICLE THERAPY LLC (APT) | 1 | 2012 |
| AUCTION.COM | 1 | 2013 |
| BIPARTISAN POLICY CENTER/NATIONAL COMMISSION ON ENERGY POLICY | 1 | 2008 |
| GS1 US | 1 | 2012 |
| PUBLIC HEALTH INSTITUTE (PHI) | 1 | 2026 |
| SKYSCANNER LIMITED | 1 | 2020 |
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025. Issues related to tourism during FIFA World Cup in 2026.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to S. 3525/H.R. 5267, The American Franchise Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
HELP Act of 2026
Client: UNITED WAY WORLDWIDE (UWW) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
HELP Act of 2026
Client: UNITED WAY WORLDWIDE (UWW) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025. Issues related to tourism during FIFA World Cup in 2026.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
American Franchise Act
Client: INTERNATIONAL FRANCHISE ASSOCIATION (IFA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to S. 3525/H.R. 5267, The American Franchise Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Hotel Fees Transparency Act of 2025
Client: AIRBNB · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025. Issues related to tourism during FIFA World Cup in 2026.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Accelerating Kids’ Access to Care Act of 2025
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: RESEARCH!AMERICA · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: MCKESSON CORPORATION · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025. Issues related to tourism during FIFA World Cup in 2026.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act.
Accelerating Kids’ Access to Care Act
Client: BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Protecting Free Speech Act
Client: ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act,
Protecting Free Speech Act
Client: ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act.
Energy Permitting Reform Act of 2024
Client: ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and a House discussion draft to amend the National Environmental Policy Act of 1969. Issues related to amending the Mineral Leasing Act to amend references of gilsonite.
Energy Permitting Reform Act of 2024
Client: ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act.
Energy Permitting Reform Act of 2024
Client: ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act,
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Facilitating Innovative Nuclear Diagnostics Act of 2023
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy including H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R.1691, The Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to appropriate reimbursement for radiopharmaceuticals.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: REFLEXION MEDICAL · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy, including H.R. 1199/S.1544, Facilitating Innovative Nuclear Diagnostics (FIND) Act and H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to cybersecurity. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to drug pricing transparency. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S. 2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to testing, vaccination, and treatment including H.R.1770/S.2477, The Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R.1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R.1770 and S.2477, the Equitable Community Access to Pharmacist Services Act. Issues related to pharmaceutical access and affordability. Issues related to pharmaceutical supply chains.
Equitable Community Access to Pharmacist Services Act
Client: CVS HEALTH · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to drug pricing transparency. Issues related to pharmacy benefit managers. Issues related to testing, vaccination and treatment including H.R. 1770 and S. 2477, the Equitable Community Access to Pharmacist Services Act. Issues related to prescription drug access and affordability.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Legislation that would permanently provide Medicare coverage of services provided by a pharmacist, including incidental services and supplies relating to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, The Equitable Community Access to Pharmacist Services Act. Issues related to drug distribution and access. Issues related to the reauthorization of the Pandemic and All Hazards Preparedness Act.
Equitable Community Access to Pharmacist Services Act
Client: ABBOTT LABORATORIES · Firm: KOUNTOUPES DENHAM CARR & REID, LLC
Legislation to expand Medicare coverage to permanently include services provided by a pharmacist, including incidental services and supplies, related to testing, drug regimens, and vaccines for COVID-19, influenza, and certain other illnesses, including H.R. 1770/S.2477, the Equitable Community Access to Pharmacist Services Act.
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S. 2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
Issues related to the Fiscal Year 2027 appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to health insurance and coverage.
Issues related to health insurance and coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U. S. CENTER FOR SAFESPORT via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to funding the U.S. Center for SafeSport, including Keep Young Athletes Safe funding in the Fiscal Year 2027 Commerce, Justice, Science Appropriations bills.
General education about the U.S. Center for Safesport. Issues related to funding for U.S. Center for SafeSport. Issues related to legislation regarding procedures at the U.S. Center for SafeSport. Issues related to athlete safety in college sports.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to S. 3525/H.R. 5267, The American Franchise Act.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.
Issues related to reimbursement and Medicare Part B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to health insurance coverage. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC HEALTH INSTITUTE (PHI) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to federal public health programs.
Issues related to federal funding of public health programs.
Filing targets: Health & Human Services, Dept of (HHS), SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to pharmaceutical supply chains and patient access.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. Issues related to diagnostic services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to Supplemental Nutrition Assistance Program and food safety.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to tariffs and generic pharmaceuticals.
Issues related to generic pharmaceuticals and drug shortages.
Filing targets: Executive Office of the President (EOP), SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices. Issues related to FDA user fees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to clinical laboratories and payment for clinical laboratory services.
Issues related to clinical laboratories and payment for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · Q3
Issues related to the supply of infant formula and nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to reimbursement and Medicare Part B.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to the role and value of community specialty physicians.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · third_quarter · RR
Issues related to health insurance and coverage.
Issues related to health insurance and coverage.
AIRBNB via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · 2T
Issues related to international tax, digital services tax, and corporate alternative minimum tax. Issues related to IRS Section 280A, The Augusta Rule, and international taxes.
Issues related to tech policy and data privacy.
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED WAY WORLDWIDE (UWW) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the 211 network and H.R. 8520, The Human-Services Emergency Logistic Program (HELP) Act of 2026.
General education about community-based charitable organizations. Issues related to tax policy and the One Big Beautiful Bill Act (Public Law 119-21), including the Child Tax Credit, Voluntary Income Tax Assistance Program, Earned Income Tax Credit and S.317/H.R. 801, The Charitable Act.
Issues related to the Fiscal Year 2027 appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U. S. CENTER FOR SAFESPORT via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to funding the U.S. Center for SafeSport, including Keep Young Athletes Safe funding in the Fiscal Year 2027 Commerce, Justice, Science Appropriations bills.
General education about the U.S. Center for Safesport. Issues related to funding for U.S. Center for SafeSport. Issues related to legislation regarding procedures at the U.S. Center for SafeSport.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRBNB via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025.
Issues related to international tax, digital services tax, and corporate alternative minimum tax. Issues related to IRS Section 280A, The Augusta Rule, and international taxes.
Issues related to tech policy and data privacy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to pharmaceutical supply chains and patient access.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE COCA-COLA COMPANY via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Supplemental Nutrition Assistance Program and food safety.
Filing targets: HOUSE OF REPRESENTATIVES
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency funding for medical and cancer research. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to tariffs and generic pharmaceuticals.
Issues related to generic pharmaceuticals and drug shortages.
Filing targets: Executive Office of the President (EOP), SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to health insurance coverage. Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to clinical laboratories and payment for clinical laboratory services.
Issues related to clinical laboratories and payment for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances. Issues related to diagnostic services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · second_quarter · Q2
Issues related to the supply of infant formula and nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL FRANCHISE ASSOCIATION (IFA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to employment and workforce policies impacting the franchise industry, including the joint employer standard. Issues related to H.R. 5267, The American Franchise Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U. S. CENTER FOR SAFESPORT via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
General education about the U.S. Center for Safesport. Issues related to funding for U.S. Center for SafeSport. Issues related to legislation regarding procedures at the U.S. Center for SafeSport.
Issues related to funding the U.S. Center for SafeSport, including Keep Young Athletes Safe funding in the Fiscal Year 2027 Commerce, Justice, Science Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to pharmaceutical supply chains and patient access.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to Medicare Advantage supplemental benefits.
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to generic pharmaceuticals and drug shortages.
Issues related to tariffs and generic pharmaceuticals.
Filing targets: SENATE
AIRBNB via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025. Issues related to tourism during FIFA World Cup in 2026.
Issues related to tech policy and data privacy.
Issues related to international tax, digital services tax, and corporate alternative minimum tax. Issues related to IRS Section 280A, The Augusta Rule, and international taxes.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to health insurance coverage.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to clinical laboratories and reimbursement for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to the supply of infant formula and nutrition.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · Q1
Issues related to Medicare reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEARTFLOW, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to Medicare reimbursement.
Issues related to Medicare reimbursement.
PROFESSIONAL COMPOUNDING CENTERS OF AMERICA (PCCA) via KOUNTOUPES DENHAM CARR & REID, LLC
2026 · first_quarter · RR
Issues related to pharmaceutical compounding.
U. S. CENTER FOR SAFESPORT via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General education about the U.S. Center for Safesport. Issues related to funding for U.S. Center for SafeSport. Issues related to legislation regarding procedures at the U.S. Center for SafeSport.
Issues related to funding the U.S. Center for SafeSport, including Keep Young Athletes Safe funding in the Fiscal Year 2026 Commerce, Justice, Science Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH!AMERICA via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General education about federal health and science research. Issues related to federal research policies including rare and neglected tropical diseases.
Issues related to the Fiscal Year 2026 appropriations process.
Issues related to research & development tax credits and incentives.
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICANN (INTERNET CORPORATION FOR ASSIGNED NAMES AND NUMBERS) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the multistakeholder approach to Internet governance and updates to ICANN registration data policy and implementation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages. Issues related to Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act.
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEAN SLATE INITIATIVE, INC. (CSI) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to automatic criminal record clearance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APOTEX, CORP. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to generic pharmaceuticals and drug shortages.
Issues related to tariffs and generic pharmaceuticals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRBNB via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to tourism, travel, user fees and short term rentals. Issues related to S.314/H.R. 1479, The Hotel Fees Transparency Act of 2025. Issues related to tourism during FIFA World Cup in 2026.
Issues related to tech policy and data privacy.
Issues related to international tax, digital services tax, and corporate alternative minimum tax. Issues related to IRS Section 280A, The Augusta Rule, and international taxes.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to health insurance coverage.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVAMED IMAGING via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
General issues related to medical device cybersecurity, artificial intelligence, and the healthcare supply chain. Issues related to coverage for certain medical devices. Issues related to the reimbursement for services furnished by medical devices in outpatient care settings. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CLINICAL LABORATORY ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to clinical laboratories and reimbursement for clinical laboratory services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · fourth_quarter · Q4
Issues related to the supply of infant formula and nutrition.
Filing targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
U. S. CENTER FOR SAFESPORT via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
General education about the U.S. Center for Safesport. Issues related to funding for U.S. Center for SafeSport. Issues related to legislation regarding procedures at the U.S. Center for SafeSport.
Issues related to funding the U.S. Center for SafeSport, including Keep Young Athletes Safe funding in the Fiscal Year 2026 Commerce, Justice, Science Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICANN (INTERNET CORPORATION FOR ASSIGNED NAMES AND NUMBERS) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to the multistakeholder approach to Internet governance and updates to ICANN registration data policy and implementation.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Natl Telecommunications & Information Administration (NTIA), SENATE
ESSENTIAL MINERALS ASSOCIATION (FORMERLY REPORTING AS IMA-NA) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to mining, critical minerals, and domestic manufacturing and supply chain issues. Issues related to federal permitting reform, including S.4753, The Energy Permitting Reform Act of 2024 and H.R. 4776, Standardizing Permitting and Expediting Economic Development (SPEED) Act,
Issues related to ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RESEARCH!AMERICA via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
General education about federal health and science research. Issues related to federal research policies including rare and neglected tropical diseases.
Issues related to the Fiscal Year 2026 appropriations process.
Issues related to research & development tax credits and incentives.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
REFLEXION MEDICAL via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy. Issues related to coverage for breakthrough medical technology.
Issues related to coding, coverage, and reimbursement for biology-guided radiotherapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHILIPS NORTH AMERICA LLC (FORMERLY REPORTING AS PHILIPS HEALTHCARE/HOLDING) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to providing veterans with access to tele-critical care and telehealth remote patient monitoring. Issues related to access to consumer medical devices.
Issues related to medical devices, remote patient monitoring, and telehealth. Issues related to the third-party servicing of medical devices and remanufacturing of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL JOB CORPS ASSOCIATON via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · 3T
Issues related to the Job Corps Program, including program oversight and management reform. Issues related to the Workforce Innovation and Opportunity Act reauthorization. Issues related to the U.S. Forest Service's Civilian Conservation Centers.
Issues related to the Job Corps Program and the Fiscal Year 2026 Labor, Health and Human Services, Education and Related Agencies Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MCKESSON CORPORATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to the pharmaceutical supply chain and drug shortages.
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to health coverage and patient access to care. Issues related to prescription drug costs and affordability. Issues related to agency finding for medical and cancer research, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to pediatric drug development.
Issues related to blood cancer research for adult and pediatric populations, including S.752/H.R. 1509, The Accelerating Kids' Access to Care Act. Issues related to health coverage and patient access to care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to pharmaceutical supply chains and patient access. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to Medicare Part D, Medicare Advantage and Medicaid.
Issues related to employer, small group, and individual insurance markets.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to telehealth. Issues related to access to compounded drugs and drug shortages.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CLEAN SLATE INITIATIVE, INC. (CSI) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to automatic criminal record clearance.
Filing targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
General issues related to over-the-counter (OTC) pharmaceutical supply chain.
Issues related to the expansion of Flexible Savings Accounts and Health Savings Accounts to include dietary supplements and oral care products as qualified medical expenses. Supply chain issues for over the counter (OTC) medicines. Issues related to FDA regulation of OTC products. Issues related to the Dietary Supplement Health and Education Act (DSHEA). Issues related to the Over-the-Counter Drug Monograph User Fee Authorization (OMUFA) Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION) via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles. Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act and S.2426, Equitable Community Access to Pharmacist Services Act.
Issues related to the pharmaceutical supply chain, drug shortages, and national stockpiles.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS OBO COALITION AGAINST SURPRISE MEDICAL BILLING via KOUNTOUPES DENHAM CARR & REID, LLC
2025 · third_quarter · Q3
Issues related to the rulemaking process for the implementation of the No Surprises Act (Public Law 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Issues related to science, technology, and biotechnology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE